| P2093 | author name string | Suhn Hee Kim | |
| | Woo Hyun Park | |
| P2860 | cites work | Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase | Q39711215 |
| | MG132, a proteasome inhibitor decreased the growth of Calu-6 lung cancer cells via apoptosis and GSH depletion | Q39740719 |
| | Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines | Q39999539 |
| | Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis | Q40131977 |
| | Quercetin inhibition of ROS-dependent and -independent apoptosis in rat glioma C6 cells | Q40285973 |
| | Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway | Q40348103 |
| | Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line | Q40545203 |
| | Proteasome inhibitors stimulate activator protein-1 pathway via reactive oxygen species production. | Q40707169 |
| | Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells | Q42806146 |
| | MG132 as a proteasome inhibitor induces cell growth inhibition and cell death in A549 lung cancer cells via influencing reactive oxygen species and GSH level | Q43201212 |
| | Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines. | Q44358960 |
| | Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells | Q44488098 |
| | Propyl gallate inhibits the growth of HeLa cells via regulating intracellular GSH level. | Q45923848 |
| | Pyrogallol as a glutathione depletor induces apoptosis in HeLa cells. | Q46572960 |
| | The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status | Q46706369 |
| | High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer | Q46831108 |
| | Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. | Q52537613 |
| | Re-examination of the reaction of diethyldithiocarbamate with the copper of superoxide dismutase | Q72902891 |
| | Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress | Q73836143 |
| | L-S,R-buthionine sulfoximine: historical development and clinical issues | Q74811892 |
| | Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked | Q24318845 |
| | Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells | Q27860926 |
| | Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression | Q28215218 |
| | The 26S proteasome: a molecular machine designed for controlled proteolysis | Q29619692 |
| | Proteasome inhibitors: valuable new tools for cell biologists | Q29620573 |
| | The role of the ubiquitin-proteasome pathway in apoptosis | Q33669467 |
| | Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis | Q33905351 |
| | Significance of ROS in oxygen sensing in cell systems with sensitivity to physiological hypoxia | Q34139832 |
| | Ubiquitin proteasome pathway: implications and advances in cancer therapy | Q34446282 |
| | Reactive oxygen species: roles in blood pressure and kidney function | Q34555173 |
| | The role of ROS and RNS in regulating life and death of blood monocytes | Q35699294 |
| | The proteasome: a suitable antineoplastic target | Q35762448 |
| | Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application | Q35783088 |
| | The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism | Q35848514 |
| | Activation of the cell death program by inhibition of proteasome function | Q35964722 |
| | Mitochondrial ROS-induced ROS release: an update and review | Q36531183 |
| | Thioredoxin in cancer--role of histone deacetylase inhibitors | Q36649242 |
| | Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis | Q37131361 |
| P433 | issue | 4 | |
| P921 | main subject | cell death | Q2383867 |
| P304 | page(s) | 1284-1291 | |
| P577 | publication date | 2012-01-19 | |
| P1433 | published in | Oncology Reports | Q7092098 |
| P1476 | title | MG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion | |
| P478 | volume | 27 | |